Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Corcept Therapeutics Inc (NASDAQ:CORT)

17.75
Delayed Data
As of Nov 22
 +0.17 / +0.97%
Today’s Change
6.70
Today|||52-Week Range
20.77
+144.49%
Year-to-Date
Valeant Closes Senior Note Offering, Reprices Term Loan
Nov 22 / Zacks.com - Paid Partner Content
Valeant (VRX) Announces Pricing of Senior Secured Notes
Nov 15 / Zacks.com - Paid Partner Content
Can Valeant (VRX) Turn Around on Rebuilding Initiatives?
Nov 21 / Zacks.com - Paid Partner Content
Roche (RHHBY) Receives FDA Clearance for Ventana MMR Test
Nov 15 / Zacks.com - Paid Partner Content
Mallinckrodt (MNK) Down 55% Year to Date: What Lies Ahead?
Nov 20 / Zacks.com - Paid Partner Content
Pacira's Exparel sNDA to be Reviewed by FDA Advisory Committee
Nov 15 / Zacks.com - Paid Partner Content
Roche Reports Positive Data From Tecentriq Combination Study
Nov 20 / Zacks.com - Paid Partner Content
Cardinal Health (CAH) to Divest Assets to Shanghai Pharma
Nov 15 / Zacks.com - Paid Partner Content
Alnylam Starts Rolling NDA Submission for RNAi Candidate
Nov 17 / Zacks.com - Paid Partner Content
Alnylam RNAi Drug Gets Accelerated Assessment Grant From EMA
Nov 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close17.58
Today’s open17.68
Day’s range17.08 - 17.82
Volume810,106
Average volume (3 months)1,406,295
Market cap$2.0B
Dividend yield--
Data as of 4:00pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+503.57%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+61.72%
P/E ratio61.2
Price/Sales9.87
Price/Book48.35

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.30-1.05%
CBMCambrex Corp-0.50-1.01%
ARRYArray Biopharma Inc+0.12+1.07%
RGENRepligen Corp-0.59-1.71%
Data as of 4:02pm ET, 11/22/2017

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)$0.17
Annual revenue (last year)$81.3M
Annual profit (last year)$8.1M
Net profit margin10.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts